Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2013; 19(42): 7433-7439
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7433
Table 1 Clinical characteristics of the 73 cirrhotic patients with liver nodules
Histopathological diagnosis
P value
DN (n = 14)w1-HCC (n = 40)w2-HCC (n = 19)
Age (mean ± SD, yr)54.9 ± 12.962.4 ± 12.263.4 ± 10.80.129
Sex0.629
Male112712
Female3137
Underlying liver disease0.640
HBV7157
HCV31510
HBV + HCV261
Alcoholism241
Child-Pugh class0.645
A102514
B4155
Tumor size (mean ± SD, cm)1.8 ± 0.62.1 ± 0.72.9 ± 2.30.365
AFP (mean ± SD, ng/mL)17.1 ± 27.955.5 ± 117.964.2 ± 169.70.202
< 20 ng/mL1228130.790
≥ 20 ng/mL2126
> 20, ≤ 100 ng/mL274
> 100, ≤ 200 ng/mL001
> 200 ng/mL051
Table 2 Interobserver agreement for magnetic resonance features
MR featuresk value
T1-weighted in-phase imaging0.853
T1-weighted opposed-phase imaging0.870
Fatty metamorphosis0.819
T2-weighted imaging0.828
Arterial enhancement0.806
Late-phase T1-weighted imaging0.743
Table 3 Comparison of magnetic resonance features between dysplastic nodule and well-differentiated hepatocellular carcinoma
DN (n = 14)wHCC
P value
w1 (n = 40)w2 (n = 19)DN vs wHCCDN vs w1w1 vs w2
In-phase T1WI0.4690.4050.074
Hyperintense8298
Isointense454
Hypointense267
Opposed-phase T1WI0.6610.5650.007
Hyperintense8254
Isointense346
Hypointense3119
Fatty metamorphosis0.1920.3110.450
Positive054
Negative143515
T2WI0.0060.0200.109
Hyperintense11412
Isointense652
Hypointense7215
Arterial enhancement0.7670.7530.005
Hypervascular51213
Iso-/hypo-vascular9286
Late-phase T1WI0.1120.2860.105
Hyperintense153
Isointense12267
Hypointense199